channels, but after exposure to PrP106-126, secretion was unaffected by N-type channel blockade. Instead, selective L-type channel blockade was as effective as Cd 2ϩ in suppressing secretion. Patch-clamp recordings revealed no change in total Ca 2ϩ current density in PrP106-126-treated cells or in the contribution to total current of L-type channels, but a small Cd 2ϩ -resistant current was found only in PrP106-126-treated cells. Thus PrP106-126 augments secretion by inducing a Cd 2ϩ -resistant Ca 2ϩ influx pathway and alters coupling of native Ca 2ϩ channels to exocytosis. These effects are likely contributory factors in the toxic cellular actions of PrP sc . regulated exocytosis; pheochromocytoma; amperometry; ion channels; toxic peptides CELLULAR PRION PROTEINS (PrP c ) are naturally occurring, copper-binding glycoproteins found primarily on neuronal and glial plasma membranes as well as those of many other cell types (2, 9, 11) . Their physiological function(s) is not well established, although available evidence [based largely on studies employing PrP cdeficient mice (reviewed in Ref. 11) ] suggests that they can modulate neuronal excitability, synaptic transmission, and intracellular Ca 2ϩ homeostasis (6, 7, 12) as well as alter sleep patterns (33) , learning, and memory processes (22) .
Prion diseases are characterized by neurodegeneration, gliosis, and accumulation of plaquelike, extracellular deposits in the brain. These diseases include scrapie (in sheep), bovine spongiform encephalopathy (in cattle), and Creutzfeldt-Jakob disease (in humans). Collectively, these disorders are referred to as transmissible spongiform encephalopathies and arise from infection with the protease-resistant scrapie form of prion (PrP sc ). After infection, the presence of PrP sc permits conversion of PrP c to PrP sc , leading to a progressive accumulation of PrP sc that is believed to underlie neurodegenerative processes manifested in the above-mentioned diseases (11) .
The cellular mechanisms by which PrP sc causes neuronal dysfunction are currently unclear but are the subject of much interest. These studies, commonly employing the PrP sc fragment 106-126 [which is functionally extremely similar to the full-length peptide (9) ], suggest that PrP sc has marked effects on Ca 2ϩ homeostasis, altering transmembrane Ca 2ϩ flux possibly by interacting with voltage-gated Ca 2ϩ channels (23, 30, 31) . In addition, prion protein fragment 106-126 (PrP106-126) has been demonstrated to form nonselective ionic channels in planar lipid bilayers (17, 18) , which could permit Ca 2ϩ entry into cells, although others have attempted and failed to reproduce such an effect (20) . This notwithstanding, the possible channelforming property of PrP106-126 is remarkably similar to one action of Alzheimer's amyloid ␤-peptides (A␤Ps) (1, 14) . We have previously shown that A␤Ps can form Ca 2ϩ -permeable channels in pheochromocytoma (PC-12) cells (a widely used neurosecretory model cell system; reviewed in Ref. 13 ) that contribute to the excessive catecholamine secretory response of these cells when they are depolarized with high-extracellular [K ϩ ]-containing solutions (25) . Such similarities in the functional effects of A␤Ps and PrP sc have prompted us to examine the effects of PrP106-126 on the secretory responses of PC-12 cells. Our results indicate that this peptide enhances evoked catecholamine secretion by inducing a novel Ca 2ϩ influx pathway that is distinct from known voltage-gated Ca 2ϩ channels. We suggest that this influx may contribute to the neurodegenerative effects of PrP sc .
MATERIALS AND METHODS
The PC-12 cells used in this study were obtained within the last year from American Type Culture Collection (Rockville, MD) and cultured as previously described (25, 26) in RPMI 1640 culture medium that contained L-glutamine and was supplemented with 20% fetal calf serum and 1% penicil-lin/streptomycin (GIBCO, Paisley, Strathclyde, United Kingdom). Cells were kept at 37°C in a humidified atmosphere of 5% CO 2-95% air, passaged every 7 days, and used for up to 20 passages. The prolonged period without medium change was believed to enhance evoked dopamine release (24) . Cells used for experiments were transferred to smaller flasks in 10 ml of medium, and 1 M dexamethasone (Sigma, Poole, UK; from a stock solution of 1 mM in ultrapure water) was applied for 72-96 h to further enhance dopamine secretion (32) .
On each experimental day, aliquots of PC-12 cells were plated onto poly-L-lysine-coated coverslips and allowed to adhere for ϳ1 h. Fragments of coverslips with attached cells were then transferred to a recording chamber (vol ϳ80 l) that was continually perfused under gravity (flow rate 1-2 ml/min) with a solution of the following composition (in mM): 135 NaCl, 5 KCl, 1.2 MgSO 4, 2.5 CaCl2, 5 HEPES, and 10 glucose, pH 7.4 (osmolality adjusted to ϳ300 mosmol/kgH2O with sucrose, 21-24°C). For experiments using solutions of raised K ϩ concentration, the Na ϩ concentration was reduced accordingly to maintain isoosmolarity. Ca 2ϩ -free solutions contained 1 mM EGTA and no added Ca 2ϩ . Drugs were applied in the perfusate except in the cases of -conotoxin GVIA (-CgTx) and -agatoxin GIVA (-Aga-IVA). The effects of these agents were investigated by preincubation of cells in extracellular solutions containing these agents for at least 10 min as previously described (25, 27) . Experiments were conducted within 3 min of transfer of these cells to the perfused recording chamber. Experiments investigating the effects of nifedipine were conducted at low-light intensity, and nifedipine was added to the perfusate from a stock solution of 20 mM in ethanol, made fresh each day. PrP106-126 and its scrambled version (used for initial control experiments, see RESULTS) were purchased from BaChem, dissolved in ultrapure water at a concentration of 1 mM, and stored at Ϫ20°C in aliquots. They were added directly to cells in culture at the concentrations indicated in RESULTS for varying periods (1-48 h) immediately before experiments.
Carbon fiber microelectrodes (Dagan Instruments) with a diameter of 5 m were positioned adjacent to individual cells and polarized to ϩ800 mV to allow oxidation of released catecholamine. Resulting currents were recorded using an Axopatch 200A amplifier (with extended voltage range), filtered at 1 kHz, and digitized at 2 kHz before storage on computer. All acquisition was performed using a Digidata 1200 interface and Fetchex software from the pCLAMP 6.0.3 suite (Axon Instruments). Unless otherwise stated, each experiment consisted of current recordings of a brief control period during which cells were perfused with standard external medium (5 mM K ϩ concentration). This was then exchanged for a test solution, and amperometric signals were recorded for a further period of 1-4 min. Catecholamine secretion was apparent as discrete spikelike events, each corresponding to the released contents of a single vesicle of catecholamine (5, 35) . Quantification of release was achieved by counting spikes using Minian 16 software (Jaejin Software, Columbia, NY). This allowed visual inspection of each event so that artifacts (due, for example, to solution switches) could be rejected from analysis. Integration of individual amperometric events allowed measurement of quantal size (see Fig. 2 ), as previously described (25, 28) .
To record Ca 2ϩ channel currents, cells were perfused with a solution of the following composition (in mM): 110 NaCl, 5 CsCl, 0.6 MgCl2, 20 BaCl2, 5 HEPES, 10 glucose, and 20 tetraethylammonium-Cl, pH 7.4. Osmolality of the perfusate was adjusted to 300 mosmol/kgH2O by addition of sucrose. Patch pipettes (5-7 M⍀ resistance) were filled with a solution of (in mM) 130 CsCl, 1.1 EGTA, 2 MgCl2, 0.1 CaCl2, 10 NaCl, 10 HEPES, and 2 Na2ATP, pH 7.2. After the whole cell configuration was established, cells were voltage clamped at Ϫ80 mV. To evoke whole cell Ca 2ϩ channel currents, 200-ms voltage ramps were applied from Ϫ100 mV to ϩ100 mV at a frequency of 0.2 Hz (10). As for amperometric recordings, evoked currents were filtered at 1 kHz, digitized at 2 kHz, and stored on computer for offline analysis.
All results are presented as individual examples or means Ϯ SE, and statistical comparisons were made using an unpaired Student's t-test unless stated otherwise.
RESULTS

Secretory responses to high (50 mM) K
ϩ -containing solutions of PC-12 cells are shown in Fig. 1 , A-C. It is apparent from these examples and from the mean exocytotic frequency plot of Fig. 1D that 24-h exposure of cells to PrP106-126 caused a concentration-depen- dent increase in the secretory response of cells, reaching a maximal increase at a PrP106-126 concentration of 1-3 M, where the response to 50 mM K ϩ was increased more than twofold. That this effect was specific to PrP106-126 was evidenced by the fact that a scrambled version of the peptide was without significant effect on K ϩ -evoked secretion (mean exocytotic frequency 0.76 Ϯ 0.15 Hz, n ϭ 8; not significantly different from control cells). In control solutions (containing 5 mM K ϩ ), no secretory events were detected in control or PrP106-126-treated cells. Measurement of quantal size, obtained by integrating individual exocytotic events, revealed no statistical difference (P Ͼ 0.2) between control and PrP106-126-treated cells in terms of mean quantal size (Fig. 2 (26, 27) . In PrP106-126-treated cells, K channels failed to prevent fully the secretory response, strongly suggesting that exposure to PrP106-126 induced a distinct Ca 2ϩ influx pathway that contributed to the secretory response. When PrP106-126 was applied for 24 h in the continual presence of Congo Red (500 M), K ϩ -evoked secretion was not significantly altered (0.83 Ϯ 0.19 Hz, n ϭ 10), and Cd 2ϩ -resistant secretion was reduced by ϳ80% (see Fig. 4 ) to 0.13 Ϯ 0.05 Hz (n ϭ 10).
The time course of emergence of the Cd 2ϩ -resistant secretory response, and indeed the enhancement of the total secretory response, was studied by exposing cells to 1 M PrP106-126 for between 1 and 48 h. Results are plotted in Fig. 4 , which shows that the time course of enhancement of total secretory response (closed circles) was followed closely by the time course of emergence of the Cd 2ϩ -resistant secretory pathway: in both cases, maximal enhancement was observed after a 6-h exposure period. This plot also reveals that the magnitude and time course of enhancement of total secretion can be accounted for by the emergence of the Cd 2ϩ -resistant component of secretion.
Our findings thus far suggested that PrP106-126-induced potentiation of the secretory response of PC-12 cells was due to the formation of a Cd (Fig. 5E) , the same as that seen for A␤P-treated cells (25) .
Control PC-12 cells possess L-, N-, and P/Q-type voltage-gated Ca 2ϩ channels (19, 27) . Ca 2ϩ influx through each of these channels can contribute to catecholamine release in a stimulus-specific manner (25) (26) (27) (28) (29) . We compared the ability of selective inhibitors of these channels to modulate K ϩ -evoked secretion from control and PrP106-126-treated cells. Statistical analysis was performed using ANOVA with both Dunnett's and Bonferroni's multiple comparison post hoc tests (both of which produced the same significance values). As shown in Fig. 6 , release evoked from control cells was mediated by Ca 2ϩ influx through L-and N-type channels, since nifedipine (an L-type channel blocker) and -CgTx (an N-type blocker) each reduced the secretory response by ϳ50% (P Ͻ 0.05 and P Ͻ 0.01, respectively), whereas -AgaTx (a P/Q-type blocker) was without significant effect. Furthermore, exposure of cells to both nifedipine and -CgTx was almost as effective as Cd 2ϩ in suppressing the secretory response. Responses in PrP106-126-treated cells were markedly different. In these cells, nifedipine was almost as effective as Cd 2ϩ in suppressing the secretory response (P Ͻ 0.01), whereas -CgTx was without significant effect [as was -AgaTx; Fig. 6 , although significant reduction (P Ͻ 0.05) was seen when both toxins were applied together]. Thus, in addition to inducing a Cd 2ϩ -resistant Ca 2ϩ influx pathway coupled to secretion, PrP106-126 appeared to prevent coupling of N-type channels to secretion, whereas coupling of L-type was promoted.
The altered pharmacology of the secretory response caused by PrP106-126 led us to investigate Ca 2ϩ influx pathways more directly, using whole cell patchclamp recordings. Figure 7 , A and B, compares mean current densities in control (Fig. 7A) and PrP106-126-treated (Fig. 7B) cells. In both cases, current density vs. voltage relationships were bell-shaped, typical of Ca 2ϩ channel currents, and were maximal in amplitude at ϩ20 mV. Importantly, and perhaps unexpectedly, mean current density was not significantly different at any activating test potential in the two groups of cells. Furthermore, Cd 2ϩ (200 M) caused near complete inhibition of these currents (open symbols, Fig. 7,  A and B) . However, as shown in Fig. 7C Given the different pharmacological profile of secretion following PrP106-126 treatment (Fig. 6) , we next investigated the contribution of L-type channels to the total whole cell Ca 2ϩ channel current in control and PrP106-126-treated cells by examining their responses to nifedipine. Results are plotted in Fig. 8 , which reveals that in control cells, nifedipine (2 M) reduced current amplitudes by 58.9 Ϯ 7.3% (as determined at ϩ20-mV test potential, P Ͻ 0.002, n ϭ 9 cells). In PrP106-126-treated cells, the same concentration of nifedipine reduced currents measured at ϩ20-mV test potential by 38.6 Ϯ 5.4% (P Ͻ 0.02, n ϭ 9). This value was not significantly different from the degree of blockade observed in control cells, indicating that the greater influence on secretion of L-type channels in PrP106-126-treated cells (Fig. 6) was not due to a selective enhancement of their expression or activity as determined at the level of whole cell patch-clamp recordings. 
DISCUSSION
In this study, we examined the cellular effects of PrP106-126, the toxic fragment of PrP sc , in the welldefined neuroendocrine cell line PC-12. Such effects of this peptide have not been extensively studied to date, despite the attention that transmissible spongiform encephalopathies have received in recent years due to contamination of the food chain and resultant implications for public health. The major observation of the present study is that PrP106-126 markedly augments evoked catecholamine release from PC-12 cells, as determined in real time using amperometry (Fig. 1) . Amperometry limits our study to specific release of catecholamine from these cells (5) , but the similar distribution of vesicular sizes in control and PrP106-126-treated cells (Fig. 2 ) strongly suggests that the same vesicular pool is mobilized during K ϩ depolarization in both groups. Importantly, the enhancement of exocytosis can be accounted for by the emergence of a Cd 2ϩ -resistant Ca 2ϩ influx pathway coupled to secretion that is not present in control cells (Figs. 3 and 4 (15) . However, such influx was observed in the absence of depolarizing stimuli. Our results suggest that if PrP106-126 does raise basal [Ca 2ϩ ] i , this is not sufficient to evoke catecholamine secretion per se. A depolarizing stimulus is still also required. The reason for this discrepancy is unclear at present, but it is noteworthy that Kawahara et al. (15) exposed cells to high peptide concentrations for brief periods of time, whereas in the present study, and in our previous investigation of the effects of A␤Ps (25), we employed much lower peptide concentrations, applied for much longer periods of time. This difference may lead to different patterns of peptide aggregation and insertion into the plasma membrane. Interestingly, these effects of PrP106-126 were almost completely inhibited by coincubation with Congo Red, which prevents aggregation of PrP and related peptides, indicating that aggregation is a requisite step in channel formation (see Ref. 17 and references therein).
Numerous similarities in the properties of ion channels formed from cytotoxic peptides have been highlighted (17) . In accordance with this, our observation that PrP106-126 potentiates evoked secretion in a manner comparable with that of A␤Ps indicates further pathophysiological similarities between these peptides. We also report similar pharmacological properties. Figure 5 indicates that Cd 2ϩ -resistant secretion is blocked by cations with a potency order La 3ϩ Ͼ Gd 3ϩ Ͼ Zn 2ϩ Ͼ Ni 2ϩ , identical to that for A␤P-mediated, Cd 2ϩ -resistant secretion induced by chronic hypoxia (25, 28) . Perhaps surprisingly, given the marked influence on secretion of PrP106-126, when we investigated this Ca 2ϩ influx pathway more directly with patch-clamp recordings, current amplitude was extremely small (Ͻ5% of total Ca 2ϩ channel current amplitude, Fig. 7 ). Once again, however, this is comparable with the effects of A␤Ps (10) . For such a small current to exert such a marked influence on secretion suggests that there may be specific localization of these channels to sites of exocytosis. For native Ca 2ϩ channels, direct binding of channel proteins to proteins associated with the exocytotic apparatus has been demonstrated (3). It is conceivable, therefore, that PrP106-126 might interact in a comparable way such that the small amount of Ca 2ϩ that enters the cell through these channels is targeted at release sites to optimize exocytotic efficiency. In this regard, it is of interest to note that PrP sc has been localized in detergent-insoluble lipid "raft" domains within cells (16, 21) . Such rafts in PC-12 cells are also enriched with soluble N-ethylmaleimide-sensitive factor attachment protein target receptor proteins essential for regulated exocytosis (4). Thus there is likely a direct association of prion proteins in the process of Ca 2ϩ -dependent exocytosis.
Modulation of existing, native voltage-gated Ca 2ϩ channels (particularly L-type channels) is a well-documented cellular effect of PrP106-126. However, the specific modulation of such channels appears variable. Thus, in astrocytes and microglia, PrP106-126 potentiates L-type channel activity (23, 30) and appears to enhance Ca 2ϩ influx through voltage-gated Ca 2ϩ channels in synaptosomes (34) . In contrast, L-type channel activity appears to be inhibited by PrP106-126 in neuroectodermal GH 3 cells and in isolated cerebellar granule neurons (8, 30, 31) . The present study indicates that in PC-12 cells, PrP106-126 does not alter the activity of L-type Ca 2ϩ channels, since their contribution to total whole cell Ca 2ϩ current density was unaffected (Fig. 8) . However, their influence on a specific cellular function was dramatically altered. Thus, after treatment with PrP106-126, nifedipine was virtually as effective as Cd 2ϩ in suppressing the secretory response to 50 mM K ϩ , and, furthermore, -CgTx was without significant effect (Fig. 6 ). This observation suggests that PrP106-126 may act intracellularly to promote coupling of exocytosis to Ca 2ϩ influx through L-type channels (without affecting their activity, as determined by patch-clamp recordings; Fig. 8 ) while inhibiting the contribution to secretion of Ca 2ϩ influx through N-type channels. The mechanism(s) underlying such an effect remains to be determined but has important potential implications for transmitter release in other cells types, since Ca 2ϩ channel expression within a given cell is targeted so that specific channel subtypes are present at transmitter release sites, such as nerve terminals or boutons (3) .
In summary, the present study indicates that PrP106-126 markedly augments evoked catecholamine secretion from PC-12 cells. This occurs largely by inducing a Cd 2ϩ -resistant Ca 2ϩ influx pathway sensitive to blockade by divalent and trivalent cations. In addition, the coupling of native, voltage-gated Ca 2ϩ channels is altered such that the influence of N-type channels on secretion is diminished and the influence of L-type is enhanced, without an increase in the contribution of these channels to total whole cell current. Our results provide novel data to indicate that PrP106-126 can exert multiple effects on secretory cells and have implications for understanding the pathophysiological actions of PrP sc at the cellular level.
